The protective effects of α-lipoic acid on kidneys in type 2 diabetic Goto-Kakisaki rats via reducing oxidative stress

International Journal of Molecular Sciences

Volumn 14, Issue 4, 2013, Pages 6746-6756

  Feng, Bo ^a   Yan, Xin Feng ^a   Xue, Jun Li ^a   Xu, Lei ^a   Wang, Hua ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

lipoic acid; Antioxidant; Diabetic nephropathy; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE SUBUNIT P22PHOX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE SUBUNIT P47PHOX; SUPEROXIDE DISMUTASE; THIOCTIC ACID; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; GENE EXPRESSION; HISTOPATHOLOGY; KIDNEY HOMOGENATE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PROTEINURIA; RAT; RENAL PROTECTION; ANIMAL; BODY WEIGHT; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; GENETICS; GLUCOSE BLOOD LEVEL; KIDNEY; METABOLISM; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; GLUTATHIONE; KIDNEY; MALE; MALONDIALDEHYDE; NADPH OXIDASE; NF-KAPPA B; ORGAN SIZE; OXIDATIVE STRESS; PROTECTIVE AGENTS; PROTEINURIA; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOCTIC ACID;

EID: 84875442186     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14046746     Document Type: Article

References (23)

1. Markell, M.S.; Friedman, E.A. Diabetic nephropathy: Management of the end-stage patients. Diabetes Care 1992, 15, 1226-1238.
2. Susztak, K.; Raff, A.C.; Schiffer, M.; Böttinger, E.P. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006, 55, 225-233.
3. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414, 813-820.
4. Horie, K.; Miyata, T.; Maeda, K.; Miyata, S.; Sugiyama, S.; Sakai, H.; van Ypersole de Strihou, C.; Monnier, V.M.; Witztum, J.L.; Kurokawa, K. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J. Clin. Invest. 1997, 100, 2995-3004.
5. Dobashi, K.; Asayama, K.; Hayashibe, H.; Uchida, N.; Kobayashi, M.; Kawaoi, A.; Kato, K. Effect of diabetes mellitus induced by streptozotocin on renal superoxide dismutases in the rat. A radioimmunoassay and immunohistochemical study. Virchows Archiv. B Cell Pathol. Incl. Mol. Pathol. 1991, 60, 67-72.
6. Schnackenberg, C.G.; Wilcox, C.S. The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int. 2001, 59, 1859-1864.
7. Melhem, M.F.; Craven, P.A.; Liachenko, J.; DeRubertis, F.R. α-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial expansion in diabetes. J. Am. Soc. Nephrol. 2002, 13, 108-116.
8. Melhem, M.F.; Craven, P.A.; Derubertis, F.R. Effects of dietary supplementation of alpha-lipoic acid on early glomerular injury in diabetes mellitus. J. Am. Soc. Nephrol. 2001, 12, 124-133.
9. Trachtman, H.; Futterweit, S.; Maesaka, J.; Ma, C.; Valderrama, E.; Fuchs, A.; Tarectecan, A.A.; Rao, P.S.; Sturman, J.A.; Boles, T.H. Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats. Am. J. Physiol. 1995, 269, F429-F438.
10. Yi, X.; Nickeleit, V.; James, L.R.; Maeda, N. α-Lipoic acid protects diabetic apolipoprotein E-deficient mice from nephropathy. J. Diabetes Complicat. 2011, 25, 193-201.
11. Sadi, G.; Eryilmaz, N.; Tütüncüoǧlu, E.; Cingir, Ş.; Güray, T. Changes in expression profiles of antioxidant enzymes in diabetic rat kidneys. Diabetes Metab. Res. Rev. 2012, 28, 228-235.
12. Arambašić, J.; Mihailović, M.; Uskoković, A.; Dinić, S.; Grdović, N.; Marković, J.; Poznanović, G.; Bajec, D.; Vidaković, M. Alpha-lipoic acid upregulates antioxidant enzyme gene expression and enzymatic activity in diabetic rat kidneys through an O-GlcNAc-dependent mechanism. Eur. J. Nutr. 2012, doi:10.1007/s00394-012-0452-z.
13. Maritum, A.C.; Sanders, R.A.; Watkins, J.B. Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J. Nutr. Biochem. 2003, 14, 288-294.
14. Malarkodi, K.P.; Sivaprasad, R.; Varalakshmi, P. Effect of lipoic acid on the oxidoreductive status of red blood cells in rats subject to oxidative stress by chronic administration of adriamycin. Hum. Exp. Toxicol. 2004, 23, 129-135.
15. Nascimento, N.R.; Costa-e-Forti, A.; Peter, A.A.; Fonteles, M.C. Free radical scavengers improve the impaired endothelium-dependent responses in aorta and kidneys of diabetic rabbits. Diabetes Res. Clin. Pract. 2003, 61, 145-153.
16. Satoh, M.; Fujimoto, S.; Haruna, Y.; Arakawa, S.; Horike, H.; Komai, N.; Sasaki, T.; Tsujioka, K.; Makino, H.; Kashihara, N. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am. J. Physiol. 2005, 288, F1144-F1152.
17. Bhatti, F.; Mankhey, R.W.; Asico, L.; Quinn, M.T.; Welch, W.J.; Maric, C. Mechanisms of antioxidant and pro-oxidant effects of a-lipoic acid in the diabetic and nondiabetic kidney. Kidney Int. 2005, 67, 1371-1380.
18. Ha, H.; Kim, K. Pathogenesis of diabetic nephropathy: The role of oxidative stress and protein kinase C. Diabetes Res. Clin. Pract. 1999, 45, 147-151.
19. Asaba, K.; Tojo, A.; Onozato, M.L.; Goto, A.; Quinn, M.T.; Fujita, T.; Wilcox, C.S. Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int. 2005, 7, 1890-1898.
20. Qi, W.; Chen, X.; Holian, J.; Mreich, E.; Twigg, S.; Gilbert, R.E.; Pollock, C.A. Transforming growth factor-beta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells. Am. J. Physiol. Renal Physiol. 2006, 291, F1070-F1077.
21. Lee, K.Y.; Ito, K.; Hayashi, R.; Mreich, E.; Twigg, S.; Gilbert, R.E.; Pollock, C.A. NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription. J. Immunol. 2006, 176, 603-615.
22. Liu, Z.; Li, S.; Chen, C. The clinical pathological characters of podocytes in diabetic nephropathy patients. J. Nephrol. Dial. Transpl. 2003, 12, 144-148.
23. Siu, B.; Saha, J.; Smoyer, W.E.; Sullivan, K.A.; Brosius, F.C., 3rd. Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: Prevention by lipoic acid treatment. BMC Nephrol. 2006, 7, 6-17.